Please wait while we load the requested S-1 report or click the link below:
https://last10k.com/sec-filings/report/1173313/000121390023032016/ea177310-s1_abvcbio.htm
November 2023
November 2023
November 2023
September 2023
August 2023
August 2023
August 2023
August 2023
July 2023
July 2023
Please wait while we load the requested S-1 report or click the link below:
https://last10k.com/sec-filings/report/1173313/000121390023032016/ea177310-s1_abvcbio.htm
Compare this S-1 Registration of Securities to its predecessor by reading our highlights to see what text and tables were removed , added and changed by American Brivision.
American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this S-1 Registration of Securities
Material Contracts, Statements, Certifications & more
American Brivision provided additional information to their SEC Filing as exhibits
Ticker: ABVC
CIK: 1173313
Form Type: S-1 Registration of Securities
Accession Number: 0001213900-23-032016
Submitted to the SEC: Mon Apr 24 2023 4:10:50 PM EST
Accepted by the SEC: Mon Apr 24 2023
Industry: Pharmaceutical Preparations